Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial
Titel:
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial
Auteur:
Sarraju, Ashish Brennan, Danielle Hayden, Kierstyn Stronczek, Amanda Goldberg, Anne C Michos, Erin D McGuire, Darren K Mason, Denise Tercek, Grace Nicholls, Stephen J Kling, Douglas Neild, Annie L Kastelein, John Davidson, Michael Ditmarsch, Marc Nissen, Steven E